Lucile Packard Children's Hospital Stanford — Palo Alto, California

Public research footprint of Lucile Packard Children's Hospital Stanford, compiled from the ClinicalTrials.gov public registry.

240

Registered studies

102

Active

Recruiting now

118

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Recurrent Osteosarcoma · Recurrent Primary Central Nervous System Neoplasm

Recently updated registry entries

NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT05691478 — A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With… (Recruiting)
NCT01503632 — Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Lucile Packard Children's Hospital Stanford?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.